首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

949765

按產品類型（藥筒，局部用藥，膠囊，Tin劑）劃分的CBD（大麻二酚）石油全球市場到2030年的行業分析和增長預測

CBD Oil Market Research Report: By Product Type (Cartridges, Topicals, Capsules, Tinctures) - Global Industry Analysis and Growth Forecast to 2030

出版日期: 2020年05月01日 | 出版商:

Prescient & Strategic Intelligence Private Limited | 英文 155 Pages | 商品交期: 2-3個工作天內

價格

全貌
簡介
目錄

簡介

2019年，全球CBD（大麻二酚）石油市場達到17.515億美元。預計到2020年至2025年，該市場的複合年增長率將達到24.3％。由於其健康益處以及可用於治療抑鬱症，運動障礙，焦慮症和疼痛，因此在具有這些問題的人們中越來越多地使用卡那比二醇。由於在美國和加拿大早日使化學合成的大麻二酚合法化，銷售額急劇增加，因此北美佔據了很大的消費份額。由於公司在種植大麻和大麻，許可成品生產和供應，擴大營銷力度以及提高公眾對大麻醫療益處的認識方面的努力，美國在該地區擁有龐大的市場。已經成為。隨著韓國，日本和澳大利亞對亞太地區（APAC）對化學合成大麻二酚的需求增加，預計該產品在未來幾年還將快速增長。

本報告調查了全球CBD（大麻二酚）石油市場，並提供了有關市場趨勢，增長和限制，按產品類型和地區進行的市場分析，競爭格局以及主要公司的概況的信息。

內容

第1章調查背景

第2章調查方法

第3章執行摘要

第4章簡介

細分市場定義
- 按產品類型
  - 藥丸
  - 膠囊
  - 外用
  - 酊劑
  - 其他
市場動態
- 市場趨勢
- 生長因子
- 抑制因子

第5章政策和法規狀態

第6章世界市場規模和預測

按產品
按地區

第7章北美市場規模和預測

按產品
按國家
- 美國市場
- 加拿大市場

第8章歐洲市場規模和預測

按產品
按國家
- 德國市場
- 意大利市場
- 荷蘭市場
- 西班牙市場
- 瑞士市場
- 英國市場

第9章亞太市場規模和預測

按產品
按國家
- 澳大利亞市場
- 日本市場
- 韓國市場

第10章其他地區的市場規模和預測

按產品
按國家
- 巴西市場
- 哥倫比亞市場
- 墨西哥市場

第11章競爭情況

主要公司的全球戰略發展
- 併購
- 產品發佈
- 聯盟
- 地域擴張
- 擴大設施
- 其他發展

第12章公司簡介

Aphria Inc.
CV Sciences Inc.
Endoca BV
Isodiol International Inc.
Aurora Cannabis Inc.
Canopy Growth Corporation
Tilray Inc.
Folium Biosciences
Gaia Botanicals LLC
CBDfx

第13章附錄

Product Code: CP12023

In numerous countries, starting with the U.S. and Canada, cannabis is being legalized for medical, recreational, and research uses. Following them, the U.K., Japan, Norway, Thailand, South Korea, Spain, Mexico, South Africa, and Brazil have also given the stamp of approval on the cultivation of marijuana and hemp, extraction of cannabidiol and usage of the chemical in various end products.

As a result, the global CBD oil market revenue is predicted to rise at a 24.3% CAGR between 2020 and 2025, from $1,735.1 million in 2019. This is being further supported by the promotion of the chemical as having numerous wellness advantages, by companies, which is helping increase the demand for it among the masses, primarily recreational users. Moreover, as cannabidiol has been claimed to treat depression, movement disorders, anxiety, and pain, its usage among people suffering from these issues is also rising.

Demand for Cannabidiol Tinctures to Burgeon in Coming Years

In the years to come, the popularity of tinctures of cannabidiol is predicted to mushroom rapidly, on account of these products being the most widely used for medical purposes. This is because tinctures can be taken sublingually (placed under the tongue), rather than via inhalation, which helps the capillaries absorb the cannabinoid instantly. Moreover, a lower dosage of tinctures is required compared to that of other forms of the chemical, which reduces the risk of the harmful effects related to overdose. Further, tinctures can be easily bought through e-commerce websites, pharmacies, and specialty and retail stores.

North America has dominated the consumption of cannabidiol till now, on account of the early legalization of the chemical in the U.S. and Canada, which has drastically increased the sale. In addition, the availability of cannabidiol-containing drugs, including Epidiolex and Sativex, and successful marketing of the compound as a wellness and lifestyle-enhancing product are other reasons for the high demand for cannabidiol in the continent. In the region, the U.S. is the larger CBD oil market, because of the increasing efforts of companies to license the cultivation of hemp and marijuana and manufacturing and supply of end-products, increase marketing activities, and make people aware about cannabis' medical benefits. In the coming years, Asia-Pacific (APAC) is predicted to experience the fastest growth in the market, due to the rising requirement for the chemical in South Korea, Japan, and Australia.

Companies Engaging in Mergers and Acquisitions to Strengthen their Hold on Industry

Mergers and acquisitions are being initiated by the market players to strengthen their presence in the industry, as such moves allow them the opportunity to:

Use the acquired companies' portfolio to expand their geographical reach

Utilize additional revenue streams

Enter new markets with cannabidiol-containing products

Advance their research and development (R&D) activities

Expand their product portfolio for core markets

Aphria Inc., Isodiol International Inc., CV Sciences Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Endoca BV, Tilray Inc., CBDfx, Folium Biosciences, and Gaia Botanicals LLC are the key companies in the global CBD oil market.

Chapter 1. Research Background

1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
- 1.3.1 Market Segmentation by Product Type
- 1.3.2 Market Segmentation by Geography
- 1.3.3 Analysis Period
- 1.3.4 Market Data Reporting Unit
  - 1.3.4.1 Value
1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research
- 2.1.1 Paid
- 2.1.2 Unpaid
2.2 Primary Research
- 2.2.1 Breakdown of Primary Research Respondents
  - 2.2.1.1 By region
  - 2.2.1.2 By industry participant
  - 2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments
- 4.1.1 By Product Type
  - 4.1.1.1 Cartridges
  - 4.1.1.2 Capsules
  - 4.1.1.3 Topicals
  - 4.1.1.4 Tinctures
  - 4.1.1.5 Others
4.2 Market Dynamics
- 4.2.1 Trends
  - 4.2.1.1 Increasing investment across CBD value chain
- 4.2.2 Drivers
  - 4.2.2.1 Legalization of CBD for research, medical, and recreational usage
  - 4.2.2.2 Brand positioning of CBD-based merchandize as lifestyle and wellness products
  - 4.2.2.3 Impact Analysis of Drivers on Market Forecast
- 4.2.3 Restraints
  - 4.2.3.1 Non-standardization of regulations and high degree of competition
  - 4.2.3.2 Impact Analysis of Restraints on Market Forecast

Chapter 5. Policy and Regulatory Landscape

Chapter 6. Global Market Size and Forecast

6.1 By Product
6.2 By Region

Chapter 7. North America Market Size and Forecast

7.1 By Product
7.2 By Country
- 7.2.1 U.S. Market
  - 7.2.1.1 By Product
- 7.2.2 Canada Market
  - 7.2.2.1 By Product

Chapter 8. Europe Market Size and Forecast

8.1 By Product
8.2 By Country
- 8.2.1 Germany Market
  - 8.2.1.1 By Product
- 8.2.2 Italy Market
  - 8.2.2.1 By Product
- 8.2.3 Netherlands Market
  - 8.2.3.1 By Product
- 8.2.4 Spain Market
  - 8.2.4.1 By Product
- 8.2.5 Switzerland Market
  - 8.2.5.1 By Product
- 8.2.6 U.K. Market
  - 8.2.6.1 By Product

Chapter 9. APAC Market Size and Forecast

9.1 By Product
9.2 By Country
- 9.2.1 Australia Market
  - 9.2.1.1 By Product
- 9.2.2 Japan Market
  - 9.2.2.1 By Product
- 9.2.3 South Korea Market
  - 9.2.3.1 By Product

Chapter 10. ROW Market Size and Forecast

10.1 By Product
10.2 By Country
- 10.2.1 Brazil Market
  - 10.2.1.1 By product
- 10.2.2 Colombia Market
  - 10.2.2.1 By product
- 10.2.3 Mexico Market
  - 10.2.3.1 By Product

Chapter 11. Competitive Landscape

11.1 Global Strategic Developments of Key Players
- 11.1.1 Mergers and Acquisitions
- 11.1.2 Product Launches
- 11.1.3 Partnerships
- 11.1.4 Geographic Expansions
- 11.1.5 Facility Expansions
- 11.1.6 Other Developments

Chapter 12. Company Profiles

12.1 Aphria Inc.
- 12.1.1 Business Overview
- 12.1.2 Product and Service Offerings
- 12.1.3 Key Financial Summary
12.2 CV Sciences Inc.
- 12.2.1 Business Overview
- 12.2.2 Product and Service Offerings
- 12.2.3 Key Financial Summary
12.3 Endoca BV
- 12.3.1 Business Overview
- 12.3.2 Product and Service Offerings
12.4 Isodiol International Inc.
- 12.4.1 Business Overview
- 12.4.2 Product and Service Offerings
12.5 Aurora Cannabis Inc.
- 12.5.1 Business Overview
- 12.5.2 Product and Service Offerings
12.6 Canopy Growth Corporation
- 12.6.1 Business Overview
- 12.6.2 Product and Service Offerings
- 12.6.3 Key Financial Summary
12.7 Tilray Inc.
- 12.7.1 Business Overview
- 12.7.2 Product and Service Offerings
- 12.7.3 Key Financial Summary
12.8 Folium Biosciences
- 12.8.1 Business Overview
- 12.8.2 Product and Service Offerings
12.9 Gaia Botanicals LLC
- 12.9.1 Business Overview
- 12.9.2 Product and Service Offerings
12.10 CBDfx
- 12.10.1 Business Overview
- 12.10.2 Product and Service Offerings